ArticleiScience2026

AIM2 in tregs restrains anti-PD-1 efficacy by reinforcing immune suppression in MC38 colorectal cancer.

Nuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.